ALEXANDRIA, Va. — The whole point of providing a prescription drug benefit in any health plan is to make sure that patients have access to the right medicines to treat their specific illnesses.
Why, then, would some analysts recommend that state officials limit the prescription drugs available through Medicaid just to generic drugs when evidence shows those may not be the right drugs for individual patients?
